- Title
- A review of natural therapies potentially relevant in triple negative breast cancer aimed at targeting cancer cell vulnerabilities
- Creator
- Webb, Myfanwy Jane; Kukard, Craig
- Relation
- Integrative Cancer Therapies Vol. 19, p. 1-18
- Publisher Link
- http://dx.doi.org/10.1177/1534735420975861
- Publisher
- Sage
- Resource Type
- journal article
- Date
- 2020
- Description
- We reviewed the research into the mechanisms of growth of triple negative breast cancer (TNBC) based on laboratory pre-clinical studies that have shaped understanding of the disease over the past decade. In response to these findings, we propose an approach to potentially prevent cancer metabolic adaptation and recurrence. This paper collates pre-clinical results, first to determine the tumor’s mechanisms of growth and then to source natural substances that could potentially suppress those mechanisms. The results from in vivo and in vitro studies of TNBC were combined first to select 10 primary mechanisms (Hypoxia-inducible factor 1α, Hedgehog, MAPK, MTAP, NF-κ B, Notch, P13K, STAT3, and Wnt signaling pathways plus p53 and POL2A gene expression) that promote TNBC growth, and second to propose a treatment array of 21 natural compounds that suppress laboratory models of TNBC via these mechanisms. We included BRCA mutations in the review process, but only pathways with the most preclinical studies utilizing natural products were included. Then we outlined potential biomarkers to assess the changes in the micro-environment and monitor biochemical pathway suppression. This suppression-centric aim targets these mechanisms of growth with the goal of potentially halting tumor growth and preventing cancer cell metabolic adaptation. We chose TNBC to demonstrate this 5-step strategy of supplementary therapy, which may be replicated for other tumor types.
- Subject
- cancer; anticancer; biomarkers; suppression; breast; empirical; targeted; translational; compounds; treatment; suppression centric anticancer natural strategy (SCANS); HIF; pre-clinical; hedgehog; NF-Kappa; notch; MAPK; MTAP; P13k; p53; STAT3; adaptation; recurrence; therapies; biochemical; pathways; natural; TNBC
- Identifier
- http://hdl.handle.net/1959.13/1426064
- Identifier
- uon:38357
- Identifier
- ISSN:1534-7354
- Rights
- Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
- Language
- eng
- Full Text
- Reviewed
- Hits: 10454
- Visitors: 10729
- Downloads: 338
Thumbnail | File | Description | Size | Format | |||
---|---|---|---|---|---|---|---|
View Details Download | ATTACHMENT02 | Publisher version (open access) | 176 KB | Adobe Acrobat PDF | View Details Download |